Germany's "National Decade Against Post-Infectious Diseases"

Possibly. Isatuximab wasn't mentioned explicitly, only her group.

Edit: speak of the devil



I feel like I'm missing something. Is Uplinza funding separate from the National Decade against Post-Infectious Diseases?

From the linked page:
In 2026, for example, a newly designed Phase II study on the efficacy and safety of the monoclonal antibody Uplizna will start.

From previous post:
For this reason, the initial research funding guidelines will not aim to promote individual therapies or specific drug candidates.
 
Back
Top Bottom